Project Grant R61DA062103
Award Date
5/15/25
Completion Date
4/30/27
Dollars Obligated
$531K
Federal Agency
National Institute on Drug Abuse
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This Project Grant award of $3,503,736, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a 2-year R61 phase and a 3-year R33 phase to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county legal systems (YILS) in Washington state. The R61 phase aims to collaboratively co-design a multilevel SUD/overdose prevention strategy and implementation...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $973,442 to The Regents of the University of California, San Francisco (UCSF) to study the effectiveness of the FOSTRSPACE digital substance use prevention tool and the ECHO telementoring implementation strategy in increasing access to substance use and mental health services for foster youth. The study aims to assess FOSTRSPACE's reach and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $357,613 to Yale University to conduct research aimed at improving the understanding of the genetic mechanisms underlying substance use disorders (SUDs). The key objectives of this 2-year project are to: 1) leverage large-scale whole-genome sequencing (WGS) datasets to identify novel rare and common genetic variants associated with SUDs and recover...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $688,271 to Yale University to conduct a comprehensive research project examining the spatial and temporal variability in a state's illicit drug market. The key products and services to be delivered under this 5-year grant, which runs from June 1, 2025 to February 28, 2030, include: 1) Expanding existing street-based testing of drug samples...
This $181,040 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to create an immersive training experience to study the genetic etiology of substance use disorders (SUDs). The award recipient, Yale University, will leverage the Million Veteran Program (MVP) biobank to: (1) model patterns of SUD co-occurrence and substance co-use, (2) utilize electronic health record data and toxicology results to provide...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a research project titled "Implementing a Digital Therapeutic to Address Substance Use Disorders Among People Who Are Incarcerated." The $355,414 award to Yale University will fund a 5-year study to assess the feasibility, acceptability, and preliminary efficacy of implementing an evidence-based digital therapeutic, Computer-Based...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,717,104 to The University of British Columbia over 3 years starting September 30, 2024. The project aims to adapt, produce, and pilot test a written "Youth Overdose Prevention Toolkit" for use by clinicians in pediatric healthcare settings in Boston, MA and Vancouver, BC. The toolkit will provide practical guidance on delivering...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,090,713 to Yale University to test the efficacy of the "Fathers for Change" intervention in reducing substance use and family violence among fathers with substance use disorders. The project will evaluate the integrated outpatient intervention, which uses fathers' roles as motivation for change and targets emotional...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $769,708 to Yale University to adapt and pilot test a Brief Negotiation Interview (BNI) intervention for reducing alcohol and cannabis misuse among assault-injured emerging adults (ages 18-25) in the emergency department setting. The 3-year project aims to: 1) assess self-efficacy, perceived peer/familial norms, and motivation to reduce...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to design tailored harm reduction strategies to address the escalating drug overdose crisis in the United States. The $2,316,128 award, with a project period from September 15, 2024 to July 31, 2028, will support collaborative efforts with health departments and community partners across six jurisdictions (Rhode Island, Massachusetts, New York...